Progressive Renal Disease Established by Renin-Coding Adeno-Associated Virus-Driven Hypertension in Diverse Diabetic Models

Journal of the American Society of Nephrology

Volumn 29, Issue 2, 2018, Pages 477-491

  Harlan, Shannon M ^a   Heinz Taheny, Kathleen M ^a   Sullivan, John M ^a   Wei, Tao ^a   Baker, Hana E ^a   Jaqua, Dianna L ^a   Qi, Zhonghua ^a   Cramer, Martin S ^a   Shiyanova, Tatiyana L ^a   Breyer, Matthew D ^a   Heuer, Josef G ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS VECTOR; BETA GALACTOSIDASE; CREATININE; I KAPPA B KINASE ALPHA; INTERLEUKIN 6; JANUS KINASE 1; JANUS KINASE 2; LISINOPRIL; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RENIN; ROSIGLITAZONE; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTOME; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; JANUS KINASE; NOS3 PROTEIN, MOUSE; SERUM ALBUMIN; STAT PROTEIN;

ALBUMIN TO CREATININE RATIO; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOPHILIA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GLOMERULOPATHY; GLOMERULUS BASEMENT MEMBRANE; HISTOPATHOLOGY; HYPERGLYCEMIA; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INCIDENCE; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MALE; MESANGIUM; MICROARRAY ANALYSIS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; RENAL SYSTEM PARAMETERS; UPREGULATION; UREA NITROGEN BLOOD LEVEL; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BLOOD; COMPLICATION; DEPENDOPARVOVIRUS; DISEASE MODEL; GENE VECTOR; GENETICS; LACTOSE OPERON; METABOLISM; NEPHRECTOMY; PATHOLOGY; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CREATININE; DEPENDOVIRUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GENETIC VECTORS; HYPERTENSION; HYPOGLYCEMIC AGENTS; JANUS KINASES; LAC OPERON; LISINOPRIL; MALE; MICE; NEPHRECTOMY; NITRIC OXIDE SYNTHASE TYPE III; RENIN; ROSIGLITAZONE; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS;

EID: 85041455350     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2017040385     Document Type: Article

References (43)

1. Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, Johansen OE, Woerle HJ, Broedl UC, Zinman B; EMPA-REG OUTCOME Investigators: Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med 375: 323-334, 2016
2. Conway BR, Rennie J, Bailey MA, Dunbar DR, Manning JR, Bellamy CO, Hughes J, Mullins JJ: Hyperglycemia and renin-dependent hypertension synergize to model diabetic nephropathy. J Am Soc Nephrol 23: 405-411, 2012
3. Van Buren PN, Toto R: Hypertension in diabetic nephropathy: Epidemiology, mechanisms, and management. Adv Chronic Kidney Dis 18: 28-41, 2011
4. Betz B, Conway BR: Recent advances in animal models of diabetic nephropathy. Nephron, Exp Nephrol 126: 191-195, 2014
5. Giunti S, Barit D, Cooper ME: Mechanisms of diabetic nephropathy: Role of hypertension. Hypertension 48: 519-526, 2006
6. Hostetter TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glo-merulopathies. Am J Med 72: 375-380, 1982
7. McMaster WG, Kirabo A, Madhur MS, Harrison DG: Inflammation, immunity, and hypertensive end-organ damage. Circ Res 116: 1022-1033, 2015
8. Kirabo A, Fontana V, de Faria AP, Loperena R, Galindo CL, Wu J, Bikineyeva AT, Dikalov S, Xiao L, Chen W, Saleh MA, Trott DW, Itani HA, Vinh A, Amarnath V, Amarnath K, Guzik TJ, Bernstein KE, Shen XZ, Shyr Y, Chen SC, Mernaugh RL, Laffer CL, Elijovich F, Davies SS, Moreno H, Madhur MS, Roberts J 2nd, Harrison DG: DC isoketal-modified proteins activate T cells and promote hypertension. J Clin Invest 124: 4642-4656, 2014
9. Zhao HJ, Wang S, Cheng H, Zhang MZ, Takahashi T, Fogo AB, Breyer MD, Harris RC: Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol 17: 2664-2669, 2006
10. Brosius FC 3rd, Alpers CE, Bottinger EP, Breyer MD, Coffman TM, Gurley SB, Harris RC, Kakoki M, Kretzler M, Leiter EH, Levi M, McIndoe RA, Sharma K, Smithies O, Susztak K, Takahashi N, Takahashi T; Animal Models of Diabetic Complications Consortium: Mouse models of diabetic nephropathy. J Am Soc Nephrol 20: 2503-2512, 2009
11. Forbes MS, Thornhill BA, Park MH, Chevalier RL: Lack of endothelial nitric-oxide synthase leads to progressive focal renal injury. Am J Pathol 170: 87-99, 2007
12. Hartono SP, Knudsen BE, Lerman LO, Textor SC, Grande JP: Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice. BMC Nephrol 15: 58, 2014
13. Meyza KZ, Defensor EB, Jensen AL, Corley MJ, Pearson BL, Pobbe RL, Bolivar VJ, Blanchard DC, Blanchard RJ: The BTBR T+ tf/J mouse model for autism spectrum disorders-in search of biomarkers. Behav Brain Res 251: 25-34, 2013
14. Thompson A: Proteinuria as a surrogate end point-more data are needed. Nat Rev Nephrol 8: 306-309, 2012
15. Inker LA, Lambers Heerspink HJ, Mondal H, Schmid CH, Tighiouart H, Noubary F, Coresh J, Greene T, Levey AS: GFR decline as an alternative end point to kidney failure in clinical trials: A meta-analysis of treatment effects from 37 randomized trials. Am J Kidney Dis 64: 848-859, 2014
16. Levey AS, Inker LA, Matsushita K, Greene T, Willis K, Lewis E, de Zeeuw D, Cheung AK, Coresh J: GFR decline as an end point for clinical trials in CKD: A scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 64: 821-835, 2014
17. Thibodeau JF, Holterman CE, Burger D, Read NC, Reudelhuber TL, Kennedy CR: A novel mouse model of advanced diabetic kidney disease. PLoS One 9: e113459, 2014
18. Cooper ME, Allen TJ, Jerums G, Doyle AE: Accelerated progression of diabetic nephropathy in the spontaneously hypertensive streptozotocin diabetic rat. Clin Exp Pharmacol Physiol 13: 655-662, 1986
19. Cooper ME, Allen TJ, Macmillan P, Bach L, Jerums G, Doyle AE: Genetic hypertension accelerates nephropathy in the streptozotocin diabetic rat. Am J Hypertens 1: 5-10, 1988
20. Cooper ME, Allen TJ, O’Brien RC, Macmillan PA, Clarke B, Jerums G, Doyle AE: Effects of genetic hypertension on diabetic nephropathy in the rat-functional and structural characteristics. J Hypertens 6: 1009-1016, 1988
21. Kelly DJ, Wilkinson-Berka JL, Allen TJ, Cooper ME, Skinner SL: A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR). Kidney Int 54: 343-352, 1998
22. Gurley SB, Clare SE, Snow KP, Hu A, Meyer TW, Coffman TM: Impact of genetic background on nephropathy in diabetic mice. Am J Physiol Renal Physiol 290: F214-F222, 2006
23. Gurley SB, Mach CL, Stegbauer J, Yang J, Snow KP, Hu A, Meyer TW, Coffman TM: Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice. Am J Physiol Renal Physiol 298: F788-F795, 2010
24. Hudkins KL, Pichaiwong W, Wietecha T, Kowalewska J, Banas MC, Spencer MW, Mühlfeld A, Koelling M, Pippin JW, Shankland SJ, Askari B, Rabaglia ME, Keller MP, Attie AD, Alpers CE: BTBR Ob/Ob mutant mice model progressive diabetic nephropathy. J Am Soc Nephrol 21: 1533-1542, 2010
25. Katz SM: Reduplication of the glomerular basement membrane. A study of 110 cases. Arch Pathol Lab Med 105: 67-70, 1981
26. Hsu H, Churg J: The ultrastructure of mucoid “onionskin” intimal lesions in malignant nephrosclerosis. Am J Pathol 99: 67-80, 1980
27. Sethi S, Iida S, Sigmund CD, Heistad DD: Renal thrombotic microangiopathy in a genetic model of hypertension in mice. Exp Biol Med (Maywood) 231: 196-203, 2006
28. Rosansky SJ, Glassock RJ: Is a decline in estimated GFR an appropriate surrogate end point for renoprotection drug trials? Kidney Int 85: 723-727, 2014
29. Schnermann J, Oppermann M, Huang Y: Nephron filtration rate and proximal tubular fluid reabsorption in the Akita mouse model of type I diabetes mellitus. F1000 Res 2: 83, 2013
30. Zhang MZ, Wang S, Yang S, Yang H, Fan X, Takahashi T, Harris RC: Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS-/- db/db mice. Am J Physiol Renal Physiol 302: F433-F438, 2012
31. Hodgin JB, Nair V, Zhang H, Randolph A, Harris RC, Nelson RG, Weil EJ, Cavalcoli JD, Patel JM, Brosius FC 3rd, Kretzler M: Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli. Diabetes 62: 299-308, 2013
32. Berthier CC, Zhang H, Schin M, Henger A, Nelson RG, Yee B, Boucherot A, Neusser MA, Cohen CD, Carter-Su C, Argetsinger LS, Rastaldi MP, Brosius FC, Kretzler M: Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy. Diabetes 58: 469-477, 2009
33. Woroniecka KI, Park AS, Mohtat D, Thomas DB, Pullman JM, Susztak K: Transcriptome analysis of human diabetic kidney disease. Diabetes 60: 2354-2369, 2011
34. Grove KJ, Voziyan PA, Spraggins JM, Wang S, Paueksakon P, Harris RC, Hudson BG, Caprioli RM: Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles. J Lipid Res 55: 1375-1385, 2014
35. Declèves AE, Sharma K: Novel targets of antifibrotic and anti-inflammatory treatment in CKD. Nat Rev Nephrol 10: 257-267, 2014
36. Wang W, Cai J, Tang S, Zhang Y, Gao X, Xie L, Mou Z, Wu Y, Wang L, Zhang J: Sinomenine attenuates angiotensin II-induced autophagy via inhibition of P47-Phox translocation to the membrane and influences reactive oxygen species generation in podocytes. Kidney Blood Press Res 41: 158-167, 2016
37. Li C, Lin Y, Luo R, Chen S, Wang F, Zheng P, Levi M, Yang T, Wang W: Intrarenal renin-angiotensin system mediates fatty acid-induced ER stress in the kidney. Am J Physiol Renal Physiol 310: F351-F363, 2016
38. Harlan SM, Ostroski RA, Coskun T, Yantis LD, Breyer MD, Heuer JG: Viral transduction of renin rapidly establishes persistent hypertension in diverse murine strains. Am J Physiol Regul Integr Comp Physiol 309: R467-R474, 2015
39. Qi Z, Whitt I, Mehta A, Jin J, Zhao M, Harris RC, Fogo AB, Breyer MD: Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal Physiol 286: F590-F596, 2004
40. Jensen EB, Gundersen HJ, Osterby R: Determination of membrane thickness distribution from orthogonal intercepts. J Microsc 115: 19-33, 1979
41. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J: Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 5: R80, 2004
42. Ihaka R, Gentleman R: R: A language for data analysis and graphics. J Comput Graph Stat 5: 299-314, 1996
43. Falcon S, Gentleman R: Using GOstats to test gene lists for GO term association. Bioinformatics 23: 257-258, 2007